GlassScriptPhysician profile
Lauren Crouse
NPI 1962135012
$6,702.68
in general payments reported to CMS, 2019-2025
18 companies · $2,184 in 2025
The $2,184 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,481 · 2024: $2,039 · 2025: $2,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,115 · Travel and Lodging: $374 · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,115.11 |
| Travel and Lodging | $373.87 |
| Education | $213.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,922.32 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $864.82 | 2023-2025 | |
| Janssen Biotech, INC. | $607.24 | 2023-2025 | Tremfya, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $573.92 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $482.80 | 2023-2025 | Ilumya, Winlevi, Blu-U |
| Galderma Laboratories, L.P. | $403.96 | 2024-2025 | Nemluvio |
| Pfizer INC. | $319.74 | 2023-2025 | |
| Dermavant Sciences, INC. | $294.33 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $257.43 | 2023-2025 | Zoryve |
| Incyte Corporation | $243.98 | 2023-2025 | Opzelura |
| Lilly USA, LLC | $120.66 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Amgen INC. | $118.07 | 2024-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $103.58 | 2025 | Libtayo |
| Genzyme Corporation | $100.53 | 2023-2024 | |
| Ucb, INC. | $92.66 | 2023-2025 | Bimzelx, Cimzia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $90.88 | 2023-2025 | Sotyktu |
| Leo Pharma INC. | $75.05 | 2023-2025 | Adbry, Anzupgo |
| Organon LLC | $30.71 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Crouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.